- Hem
- Om universitetet
- Hitta person
- Lovisa Sjögren
Lovisa Sjögren
Anknuten till forskning
Avd för pediatrik-
Family meals on prescription as treatment for childhood obesity-a randomized controlled
trial
Terese Torstensson, Anna Bohlin, Gerd Almqvist-Tangen, Josefine Roswall, Jenny Kindblom, Lovisa Sjögren
EUROPEAN JOURNAL OF PEDIATRICS - 2024 -
Neurodevelopmental disorders in children seeking obesity treatment- associations with intellectual ability and psychiatric
conditions
Maria Dellenmark-Blom, Kajsa Jarvholm, Lovisa Sjögren, Anna Levinsson, Jovanna Dahlgren
FRONTIERS IN PSYCHIATRY - 2024 -
Family screening for neurodevelopmental problems and its associations with child cognitive function enable tailored treatment for childhood
obesity
Maria Dellenmark-Blom, Kajsa Jaervholm, Lovisa Sjögren, Anna Levinsson, Jovanna Dahlgren
ACTA PAEDIATRICA - 2024 -
Systematic Development of National Guidelines for Obesity Care: The Swedish
Approach
Paulina Nowicka, Lovisa Sjögren, Ann-Sofie Bertilsson, Kajsa Jarvholm, Fanny Sellberg, Magnus Sundbom, Liv Thalen, Ylva Trolle Lagerros
OBESITY FACTS - 2024 -
Metabolic and Bariatric Surgery in Adolescents: For Whom, When, and
How?
Annika Janson, Kajsa Jarvholm, Lovisa Sjögren, Jovanna Dahlgren, Andrew J. Beamish, Eva Gronowitz, Torsten Olbers
HORMONE RESEARCH IN PAEDIATRICS - 2023 -
Metabolic and bariatric surgery versus intensive non-surgical treatment for adolescents with severe obesity (AMOS2): a multicentre, randomised, controlled trial in
Sweden
K. Jarvholm, A. Janson, M. Peltonen, M. Neovius, Eva Gronowitz, My Engström, Anna Laurenius, A. J. Beamish, Jovanna Dahlgren, Lovisa Sjögren, T. Olbers
Lancet Child & Adolescent Health - 2023 -
Adolescents' and professionals' experiences of metabolic and bariatric surgery and requirements for preoperative and postoperative support through mHealth: a qualitative
study
U. Müssener, M. Örn, T. Olbers, M. Löf, Lovisa Sjögren
Bmj Open - 2022 -
High prevalence of neurodevelopmental problems in adolescents eligible for bariatric surgery for severe
obesity.
Anna Björk, Jovanna Dahlgren, Eva Gronowitz, Fanny Henriksson Wessely, Annika Janson, My Engström, Lovisa Sjögren, Torsten Olbers, Kajsa Järvholm
Acta paediatrica - 2021 -
Prevalence of overweight and obesity from 5 to 19 years of age in Gothenburg,
Sweden
Maria Bygdell, Jimmy Célind, Lina Lilja, Jari Martikainen, L. Simonson, Lovisa Sjögren, Claes Ohlsson, Jenny Kindblom
Acta Paediatrica - 2021 -
Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort
study
Lovisa Sjögren, Erik Stenberg, Meena Thuccani, Jari Martikainen, Christian Rylander, Ville Wallenius, Torsten Olbers, Jenny Kindblom
PLoS ONE - 2021 -
Postprandial effects of the phosphodiesterase-5 inhibitor tadalafil in people with well-controlled Type 2 diabetes mellitus: a randomized controlled
trial.
Lovisa Sjögren, Josefin Olausson, Lena Strindberg, Reza Mobini, Per Fogelstrand, Lillemor Mattsson Hultén, Per-Anders Jansson
Diabetic medicine : a journal of the British Diabetic Association - 2016 -
Vascular and metabolic effects of selective PDE-5 inhibition - clinical and experimental
studies
Lovisa Sjögren
2015 -
Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2
diabetes
Per-Anders Jansson, G. Murdolo, Lovisa Sjögren, Britta Nyström, Mikaela Sjöstrand, Lena Strindberg, Peter Lönnroth
DIABETOLOGIA - 2010 -
Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects--no change following a mixed
meal.
M Sjöstrand, Per-Anders Jansson, Jenny Palming, J de Schoolmeester, D Gill, A Rees, Lovisa Sjögren, T Persson, Jan W Eriksson
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme - 2010